mevastatin has been researched along with ubiquinone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carson, DD; Lennarz, WJ | 1 |
| Haba, T; Koizumi, J; Mabuchi, H; Miyamoto, S; Sakai, Y; Takeda, R; Tatami, R; Wakasugi, T; Watanabe, A | 2 |
| Nambudiri, AM; Ranganathan, S; Rudney, H | 1 |
| Chen, GZ; Luján, HD; Mowatt, MR; Nash, TE | 1 |
| Burke, LP; Lewis, LD; Perez, RP | 1 |
| Bosia, A; Campia, I; Gazzano, E; Ghigo, D; Pescarmona, G; Riganti, C | 1 |
| Bosia, A; Campia, I; Ghigo, D; Lussiana, C; Pescarmona, G; Riganti, C | 1 |
8 other study(ies) available for mevastatin and ubiquinone
| Article | Year |
|---|---|
Inhibition of polyisoprenoid and glycoprotein biosynthesis causes abnormal embryonic development.
Topics: Animals; Anti-Bacterial Agents; Cholesterol; Diterpenes; Dolichols; Gastrula; Glycoproteins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mannose; Morphogenesis; Naphthalenes; Sea Urchins; Ubiquinone | 1979 |
Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.
Topics: Adult; Aged; Cholesterol; Female; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Lovastatin; Male; Middle Aged; Naphthalenes; Triglycerides; Ubiquinone | 1981 |
The regulation of ubiquinone synthesis in fibroblasts: the effect of modulators of beta-hydroxy-beta-methylglutaryl-coenzyme A reductase activity.
Topics: Acetates; Cell Line; Culture Media; Fibroblasts; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Naphthalenes; Ubiquinone | 1981 |
Isoprenylation of proteins in the protozoan Giardia lamblia.
Topics: Acetylcysteine; Animals; Cholesterol; Cyclohexenes; Dolichols; Giardia lamblia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Limonene; Lipid Metabolism; Lovastatin; Mevalonic Acid; Monoterpenes; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Protozoan Proteins; Terpenes; Ubiquinone | 1995 |
Ubiquinone does not rescue acute myeloid leukemia cells from growth inhibition by statins.
Topics: Acute Disease; Cell Division; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukemia, Myeloid; Lovastatin; Myelodysplastic Syndromes; Tumor Cells, Cultured; Ubiquinone | 2003 |
Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
Topics: Anticholesteremic Agents; Coenzymes; History, 20th Century; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins; Lovastatin; Ubiquinone | 2004 |
Digoxin and ouabain increase the synthesis of cholesterol in human liver cells.
Topics: Cardiotonic Agents; Cholesterol; Digoxin; Enzyme Inhibitors; Hepatocytes; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Ouabain; Sterol Regulatory Element Binding Protein 2; Ubiquinone | 2009 |
Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis.
Topics: Cell Death; Cell Line, Tumor; Cell Proliferation; Cholesterol; Diterpenes; Electron Transport; Hep G2 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mitochondria; Monocytes; Terpenes; Ubiquinone | 2009 |